Bitcoin has been stuck in a narrow trading range between $62,000 and $66,000 for several weeks due to balanced pressures from ETF buying and selling by miners and corporate treasuries. Strategy, led by Michael Saylor, unexpectedly sold over 6,900 BTC worth $440 million since June, adding downward pressure despite ETF inflows. Market liquidity is at a three-year low, limiting price movement, while investors await the U.S. Consumer Price Index report for a potential market catalyst. Technical indicators show a buy signal, but the $60,000 support level is critical to watch for future direction.
Industrial Alliance Securities lowered Abeona Therapeutics' price target from $20 to $15 following a 14% stock drop after the company reported Q2 revenues of $11.4 million, missing analyst expectations. The company faces operational challenges with i...
Inovio Pharmaceuticals is progressing its DNA medicine pipeline with its lead candidate INO-3107 for Recurrent Respiratory Papillomatosis under FDA accelerated review, targeting a decision by October 30, 2026. The company raised $18.3 million in fund...
Morin Brit, a director at Life360, sold 15,582 shares of the company, generating $1 million from the transaction. This sale may indicate a personal financial decision or portfolio adjustment by the director. Investors might watch for any further insi...
AbCellera Biologics announced positive Phase 2 trial results for its experimental menopause drug ABCL635, which significantly reduced hot flash frequency by 83%. The stock surged 33.19% to a 52-week high of $11.32, boosting the company's market cap t...
TOMI Environmental Solutions reported a 118% year-over-year revenue increase to $2.25 million, surpassing analyst estimates of $1.84 million. The company also beat EPS expectations with a loss of $0.05 per share, better than the anticipated loss of $...
